We revealed that CXXC5 expression in breast cancer is upregulated by vitamin B2 stimulation and that the expression level of CXXC5 is negatively correlated with vitamin D treatment and positively correlated with the degree of malignancy and poor prognosis of breast carcinomas. Here, CXXC5 is linked to breast cancer.